Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
2.190
-0.160 (-6.81%)
Nov 5, 2024, 3:49 PM EST - Market open

Envoy Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Net Income
-13.63-29.91-15.92-8.68
Depreciation & Amortization
0.150.130.080.07
Loss (Gain) From Sale of Assets
---0
Stock-Based Compensation
1.841.58--
Other Operating Activities
-6.8711.57.21.75
Change in Accounts Receivable
-0.12-0.030.05-0.02
Change in Inventory
-0.46-0.01-0.190.06
Change in Accounts Payable
-0.770.550.340.23
Change in Other Net Operating Assets
-1.51-1.47-0.36-0.35
Operating Cash Flow
-21.36-17.65-8.81-6.94
Capital Expenditures
-0.44-0.15-0.22-0.13
Investing Cash Flow
-0.98-0.15-0.22-0.13
Long-Term Debt Issued
-1088
Net Debt Issued (Repaid)
10.51088
Issuance of Common Stock
1.790.11--
Other Financing Activities
11.7411.740.090.06
Financing Cash Flow
24.0321.858.098.06
Foreign Exchange Rate Adjustments
-0.01-0-0.01-0.01
Net Cash Flow
1.684.04-0.940.99
Free Cash Flow
-21.8-17.81-9.02-7.06
Free Cash Flow Margin
-7219.54%-5635.13%-3807.17%-2277.74%
Free Cash Flow Per Share
-1.26-1.42-0.89-0.70
Levered Free Cash Flow
-8.05-6.54-5.17-
Unlevered Free Cash Flow
-7.95-6.54-5.17-
Change in Net Working Capital
-2.93-3.39-0.41-
Source: S&P Capital IQ. Standard template. Financial Sources.